Literature DB >> 29603336

Dual anticoagulation with fondaparinux and dabigatran for treatment of cancer-associated hypercoagulability.

Hanny Al-Samkari1, Jean M Connors2.   

Abstract

Entities:  

Keywords:  Dual anticoagulation; cancer and thrombosis; dabigatran; fondaparinux; venous thromboembolism

Mesh：

Substances：

Year:  2018        PMID： 29603336     DOI： 10.1002/ajh.25101

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  3 in total

Review 1.  Managing the competing risks of thrombosis, bleeding, and anticoagulation in patients with malignancy.

Authors:  Hanny Al-Samkari; Jean M Connors
Journal:  Blood Adv       Date:  2019-11-26

2.  Managing the competing risks of thrombosis, bleeding, and anticoagulation in patients with malignancy.

Authors:  Hanny Al-Samkari; Jean M Connors
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

Review 3.  Direct oral anticoagulants for treatment and prevention of venous thromboembolism in cancer patients.

Authors:  Andrew B Song; Rachel P Rosovsky; Jean M Connors; Hanny Al-Samkari
Journal:  Vasc Health Risk Manag       Date:  2019-06-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.